𧬠ICD-10 CM I12.9 β Hypertensive Chronic Kidney Disease With Stage 1 Through Stage 4 Chronic Kidney Disease, Or Unspecified Chronic Kidney Disease
Billable Code Confirmed
ICD-10 CM I12.9 is a complete 5-character code requiring no further specificity, making it fully billable for inpatient and outpatient reporting. The code structure follows I12 (category for hypertensive CKD) with the 4th character β9β indicating CKD stage 1-4 or unspecified, as opposed to β0β which indicates stage 5 or ESRD. Because ICD-10-CM presumes a causal relationship between hypertension and CKD when both are documented, this combination code is assigned even without the provider explicitly stating βdue toβ or βcaused by.β This presumption makes I12.9 one of the most frequently used combination codes in inpatient nephrology and internal medicine coding.
Non-Billable Parent Codes
I12 β Hypertensive chronic kidney disease β this is a category-level code requiring a 4th character to specify whether stage 5/ESRD (I12.0) or stage 1-4/unspecified (I12.9) is present, so it cannot be reported alone. I10-I16 β Hypertensive diseases β this is a block-level grouping that organizes hypertension-related codes and does not represent a reportable diagnosis.
Clinical Context
The clinical distinction driving I12.9 versus I12.0 hinges entirely on the CKD stage: I12.0 is used only when the patient has stage 5 CKD or end-stage renal disease (ESRD), often requiring or anticipating dialysis. I12.9 captures all other documented stages (1-4) as well as cases where the provider has not specified a stage at all. This means a chart with βhypertension with CKDβ and no further detail still defaults to I12.9 rather than triggering a query in most cases, though best practice encourages querying for stage specificity when clinically relevant to capture additional N18.x codes.
Code Classification
ICD-10 CM2 I12.9 is a diagnosis code used to report a chronic medical condition reflecting the relationship between hypertension and kidney disease. It is not a procedure code and has no associated laterality, since the kidneys are affected bilaterally by this systemic process in the vast majority of documented cases.
π Code Description
Hypertensive chronic kidney disease with stage 1-4 or unspecified CKD (I12.9) is a combination code that links essential hypertension to coexisting chronic kidney disease without specifying ESRD. ICD-10-CM guidelines instruct coders to assume a cause-and-effect relationship between hypertension and CKD whenever both conditions are documented in the same encounter, even if the provider does not explicitly link them. This presumptive linkage is a departure from typical coding rules, which usually require explicit documentation of causality, and reflects the well-established clinical understanding that long-standing hypertension is a leading cause of progressive kidney damage. Coders working in N18.9 or stage-specific N18.30 documentation environments should always cross-reference the hypertension status of the patient, since failing to apply I12.9 when both conditions coexist is a common compliance and risk-adjustment error.
When a provider documents βhypertensionβ and βCKD stage 3β separately in the same record, the correct approach is to assign I12.9 as the combination code and then add N18.30 as a secondary code to capture the specific stage, rather than coding I10 and N18.3x independently. This sequencing ensures both the causal relationship and the severity of kidney involvement are reflected for DRG assignment, HCC risk adjustment, and quality reporting purposes. If the documentation instead reflects stage 5 CKD or ESRD, the coder must pivot to I12.0 rather than I12.9, and should also consider whether N18.6 is appropriate as an additional code. Inpatient coders should remain alert to discharge summaries that update CKD staging from admission labs, as eGFR trends documented during the stay may justify a different stage code than what was present on admission.
π³ Code Tree / Hierarchy
I10-I16 Hypertensive diseases β Non-billable
β
βββ I10 Essential (primary) hypertension β
Billable
βββ I11.- Hypertensive heart disease β Non-billable (requires 4th character)
β β
β βββ I11.0 Hypertensive heart disease with heart failure β
Billable
β βββ I11.9 Hypertensive heart disease without heart failure β
Billable
β
βββ I12 Hypertensive chronic kidney disease β Non-billable
β β
β βββ I12.0 Hypertensive chronic kidney disease with stage 5 CKD or ESRD β
Billable
β βββ I12.9 Hypertensive CKD with stage 1-4 or unspecified CKD β THIS CODE β
Billable
β
βββ I13.- Hypertensive heart and chronic kidney disease β Non-billable (requires further characters)
Stage Specificity Drives Risk Adjustment
Selecting I12.9 alone versus I12.9 plus an N18.x stage code can change the HCC mapping and RAF score for the encounter, so always check for documented eGFR or staging language before finalizing the code set.
Tip
Remember that I12.9 is assigned by default whenever hypertension and CKD (stages 1-4 or unspecified) coexist, even without an explicit causal statement from the provider, per ICD-10-CM combination code conventions.
β Includes
- Arteriosclerosis of kidney documented in conjunction with hypertension and CKD stages 1-4 or unspecified.
- Arteriosclerotic nephritis, chronic or interstitial, when hypertension is also present.
- Hypertensive nephropathy without documentation of stage 5/ESRD.
- Hypertensive nephrosclerosis affecting kidney function at a non-ESRD stage.
- Nephrosclerosis documented as occurring with hypertension, regardless of specified CKD stage 1-4.
- Chronic kidney disease of any stage 1-4, or unstaged, occurring concurrently with essential hypertension.
β Excludes
Excludes 1
I13.0 β Hypertensive heart and chronic kidney disease with heart failure and stage 1-4 CKD β excluded because when both hypertensive heart disease and CKD are documented together, a combination code from the I13 category must be used instead of separately reporting I11 and I12 codes. I15.0 β Renovascular hypertension β excluded because I12.9 presumes essential (primary) hypertension causing the CKD; if the hypertension is documented as secondary to renal artery stenosis or another identifiable cause, an I15 code must be used instead.
Danger
The most common Excludes 1 error is failing to recognize when heart failure documentation alongside hypertension and CKD should trigger an I13 combination code rather than separate reporting of I11.9 and I12.9, which can result in an incomplete clinical picture and missed CC/MCC capture.
Excludes 2
N18.4 β Chronic kidney disease, stage 4 (severe) β not mutually exclusive; this code is reported as an additional code alongside I12.9 whenever the provider documents the specific CKD stage, since I12.9 itself does not convey severity.
π Clinical Overview
I12.9 vs I12.0 vs I13.10 β Distinguishing Combination Codes
Inpatient coders frequently encounter overlapping documentation of hypertension, kidney disease, and heart disease, making it essential to distinguish between these three combination codes. The primary driver for I12.9 versus I12.0 is the CKD stage (1-4/unspecified vs. 5/ESRD), while the driver for I12.9 versus I13.10 is whether hypertensive heart disease is also documented. Misidentifying which combination code applies can significantly affect both the DRG assignment and the HCC risk score for the encounter.
| Feature | I12.9 | I12.0 | I13.10 |
|---|---|---|---|
| CKD Stage | Captures stage 1-4 CKD or unspecified stage, without indication of ESRD or dialysis dependence in the documentation. | Reserved specifically for stage 5 CKD or documented ESRD, often with dialysis status also coded separately. | Captures hypertensive heart disease with CKD stage 1-4 or unspecified, similar staging logic to I12.9 but with heart involvement. |
| Heart Disease Component | No heart disease component is captured by this code; a separate code would be needed if hypertensive heart disease is also present. | No heart disease component captured; heart failure or heart disease would require separate or alternative combination coding. | Requires documentation of hypertensive heart disease without heart failure alongside the CKD component, distinguishing it from I13.0 and I13.2 which involve heart failure. |
| HCC/RAF Impact | Maps to HCC 326 in CMS-HCC V28, with RAF impact dependent on whether an additional stage-specific N18.x code is also reported. | Maps to a higher-weighted HCC category reflecting the severity of ESRD, often paired with dialysis status codes (Z99.2) for full risk capture. | Maps to HCC categories reflecting both cardiac and renal components, generally resulting in a different RAF profile than I12.9 alone. |
Important
A CDI trigger should be considered whenever a chart documents βrenal insufficiencyβ or βkidney diseaseβ alongside hypertension without specifying ESRD, dialysis status, or a CKD stage, since this ambiguity prevents optimal code assignment and risk capture for I12.9 or its more specific N18.x companion code.
Manifestations & Symptom Burden
- Elevated serum creatinine and reduced eGFR reflecting impaired kidney filtration in the setting of long-standing hypertension.
- Proteinuria or microalbuminuria, often an early indicator of hypertensive nephropathy before significant eGFR decline occurs.
- Electrolyte imbalances such as hyperkalemia, which may become more pronounced as CKD stage progresses toward stage 4.
- Fluid retention and peripheral edema, particularly in later CKD stages, which may complicate hypertension management.
- Fatigue and anemia related to decreased erythropoietin production as kidney function declines.
Tip
Manifestations of CKD such as anemia (D63.1) or secondary hyperparathyroidism may be separately codeable when documented as due to the CKD, but coders should verify that the provider has linked these manifestations to the CKD diagnosis before assigning additional codes, as I12.9 itself does not automatically justify coding every downstream manifestation.
π° HCC Risk Adjustment
| Attribute | Detail |
|---|---|
| HCC Model | CMS-HCC V28 |
| HCC Category | HCC 326 β Hypertension and Chronic Kidney Disease, Stage 1-4 |
| RAF Impact | Moderate; varies based on whether a companion N18.x stage code is also captured |
| Annual Capture Required | Yes |
| Companion Codes for Full Capture | N18.1, N18.2, N18.30, N18.4 (if documented) |
ICD-10 CM I12.9 is a risk-adjusting diagnosis under CMS-HCC V28, meaning its presence on a claim directly contributes to the patientβs overall risk score and the associated capitation or payment adjustment. Because the code itself does not specify CKD stage, payers and risk adjustment auditors often look for a companion N18.x code to validate that the full clinical picture has been captured; absence of a stage code does not invalidate I12.9 but may represent a missed opportunity for additional risk capture. Annual recapture is required under HCC methodology, meaning providers and coders must ensure this diagnosis (and its supporting documentation) appears at least once during each calendar year for the patientβs risk score to remain accurate. For Medicare Advantage and other risk-adjusted payer populations, consistent year-over-year documentation of hypertensive CKD is a frequent target of RADV audits, making accurate I12.9 assignment and supporting chart documentation especially important.
π₯ MS-DRG Assignment
| DRG | Title | CC/MCC Status |
|---|---|---|
| DRG 682 | Renal Failure with MCC | Requires a separately documented MCC; I12.9 alone does not qualify |
| DRG 683 | Renal Failure with CC | Requires a separately documented CC; I12.9 alone does not qualify |
| DRG 684 | Renal Failure without CC/MCC | Default if no CC/MCC is present |
ICD-10 CM I12.9 functions primarily as a secondary diagnosis in most inpatient encounters rather than as the principal diagnosis driving a DRG triad on its own. When renal failure or another kidney-related condition serves as the principal diagnosis, I12.9 may be reported as an additional diagnosis reflecting the patientβs chronic hypertensive kidney status, but it does not by itself carry CC or MCC weight. The CC/MCC status of the encounter is far more likely to be influenced by a specific CKD stage code (such as N18.4 for stage 4, which is often a CC) or by an unrelated acute condition. A common sequencing pitfall is placing I12.9 as the principal diagnosis when a more acute condition, such as acute kidney injury (N17.9), is actually the reason for admission and should be sequenced first. Coders should also verify whether dialysis status (Z99.2) needs to be reported alongside the CKD stage code, as this can further affect DRG assignment in stage 5 scenarios, though that pathway would point toward I12.0 rather than I12.9.
π Related ICD-10-CM Codes
Hypertensive Disease Family: I10, I11.9, I12.0, I13.10, I13.2
CKD Staging Companion Codes: N18.1, N18.2, N18.30, N18.4, N18.9
π οΈ Commonly Associated CPT Codes
99232 β Subsequent hospital care, expanded problem focused or detailed interval history and exam, often used when managing hypertensive CKD as a secondary condition during an inpatient stay; billing should reflect the complexity of managing both the hypertensive and renal components.
99291 β Critical care, first 60 minutes, applicable when a patient with hypertensive CKD presents with an acute decompensation requiring critical care-level management, though the critical care diagnosis itself would typically be the acute condition rather than I12.9.
36556 β Insertion of a central venous catheter, age 5 or older, which may be relevant if the hypertensive CKD has progressed to a point requiring central access for fluid management or medication administration during the inpatient stay.
90935 β Hemodialysis procedure, single physician evaluation, relevant only if the patientβs CKD has progressed to dialysis dependence; this would typically prompt reconsideration of I12.0 rather than I12.9 if ESRD is now documented.
NCCI Bundling Considerations
Because I12.9 is a diagnosis code, it does not directly participate in NCCI procedure-to-procedure bundling edits, but it does play a role in establishing medical necessity for E/M services and procedures related to hypertension and kidney disease management. When reporting evaluation and management codes alongside procedures such as dialysis access placement, coders should ensure the diagnosis codes reported, including I12.9 and any companion N18.x code, support the medical necessity documentation required by the payer. Inpatient profee coders should also confirm that the hypertensive CKD diagnosis is documented as actively managed or evaluated during the encounter (per MEAT criteria) to support its inclusion on the claim, rather than simply listed as part of the patientβs history.
π¬ ICD-10-PCS Crosswalk
ICD-10 CM I12.9, as a diagnosis code, does not have a direct one-to-one ICD-10-PCS crosswalk, since ICD-10-PCS codes represent procedures rather than diagnoses. However, if the encounter involves a procedure related to the hypertensive CKD, such as renal biopsy or dialysis access, the PCS code would be selected based on the procedure performed, with I12.9 serving as a supporting diagnosis. For example, percutaneous insertion of a dialysis catheter into the abdominal vein would utilize a PCS code from the Medical and Surgical section, root operation Insertion, body system Urinary System, with the diagnosis I12.0 (rather than I12.9) typically more relevant in that ESRD-driven scenario.
π Coding Scenarios and Examples
Scenario 1: A 68-year-old male is admitted for community-acquired pneumonia. His past medical history includes hypertension and CKD stage 3, both of which are addressed during the stay with continuation of his home antihypertensive regimen and renal-dosed medication adjustments. Codes: J18.9, I12.9, N18.3x Sequencing: J18.9 is sequenced as the principal diagnosis since it is the reason for admission, with I12.9 and N18.3x sequenced as secondary diagnoses reflecting the actively managed chronic conditions. CDI Note: If the provider only documented βhypertensionβ and βCKD stage 3β without linking them, the combination code I12.9 is still assigned per ICD-10-CM guidelines presuming the causal relationship, with N18.3x added for stage specificity.
Scenario 2: A 74-year-old female with long-standing hypertension is admitted with worsening renal function. Labs show eGFR consistent with stage 4 CKD, and the provider documents βhypertensive nephropathy, CKD stage 4.β Codes: I12.9, N18.4 Sequencing: Depending on the reason for admission, I12.9 may be principal if the encounter is specifically for management of the hypertensive CKD, with N18.4 sequenced immediately after to capture the stage. CDI Note: N18.4 being a CC-bearing code makes its capture important for DRG weighting; coders should query if stage documentation is ambiguous or only reflects a single lab value without provider confirmation.
Scenario 3: A patient with documented hypertension and CKD stage 5 on dialysis is admitted for an unrelated orthopedic procedure. The hypertensive CKD is monitored throughout the stay. Codes: I12.0, N18.6, Z99.2 Sequencing: The orthopedic procedure diagnosis is principal, with I12.0 (not I12.9) sequenced as a secondary diagnosis due to the ESRD documentation, alongside N18.6 and Z99.2 for dialysis status. CDI Note: This scenario illustrates why I12.9 would be incorrect here; the stage 5/ESRD documentation mandates I12.0 instead, demonstrating the importance of reviewing the full chart for staging language before finalizing the hypertensive CKD code.
β οΈ Coding Pitfalls and Tips
Pitfall 1: Assigning I10 and a separate N18.x code instead of the combination code I12.9 when both hypertension and CKD (stages 1-4) are documented, which violates the ICD-10-CM presumptive causality guideline and results in an incomplete diagnosis profile for risk adjustment purposes.
Pitfall 2: Failing to query for CKD stage when only βCKDβ or βrenal insufficiencyβ is documented without a stage, resulting in I12.9 being reported without a companion N18.x code and a missed opportunity for additional HCC capture under CMS-HCC V28.
Pitfall 3: Confusing I12.9 with I12.0 when the chart contains conflicting documentation, such as an admission note stating βCKD stage 3β but a discharge summary reflecting new dialysis initiation, which would actually warrant I12.0 and additional dialysis-related codes.
Pitfall 4: Overlooking the need for I13.10 or another I13 combination code when hypertensive heart disease is documented alongside the hypertensive CKD, since reporting I11.9 and I12.9 separately is an Excludes 1 violation.
Pitfall 5: Assuming I12.9 alone will support a CC/MCC designation for DRG purposes, when in fact the CC/MCC weight typically comes from the companion N18.4 (stage 4 CKD) or an unrelated acute diagnosis, not from I12.9 itself.
Pitfall 6: Coding I12.9 based solely on a problem list entry from a prior encounter without confirming the condition was evaluated, assessed, monitored, or treated (MEAT criteria) during the current inpatient stay, which can lead to denial on audit for lack of supporting documentation.
π Sources
1 2 3 4 5 6
1 CMS, ICD-10-CM Official Guidelines for Coding and Reporting, FY20262 CDC/NCHS, ICD-10-CM Tabular List of Diseases and Injuries, FY2026
3 CMS, CMS-HCC Risk Adjustment Model V28 Documentation, 2025
4 CMS, MS-DRG Definitions Manual, Version 43, 2025
5 AHA Coding Clinic for ICD-10-CM/PCS, Hypertension and CKD Combination Coding Guidance, 2025
6 AAPC, Inpatient Coding Reference β Hypertensive Chronic Kidney Disease, 2025